1 00:00:02,520 --> 00:00:08,720 Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The. 2 00:00:08,720 --> 00:00:12,560 Speaker 2: Stock Movers report, your roundup of companies making moves in 3 00:00:12,600 --> 00:00:16,160 Speaker 2: the stock market, harnessing the power of Bloomberg data. 4 00:00:16,280 --> 00:00:17,520 Speaker 3: Let's take a look at some of the stocks on 5 00:00:17,560 --> 00:00:20,320 Speaker 3: the move today on Paul Sweeney alongside Scarlatfu and we're 6 00:00:20,360 --> 00:00:20,760 Speaker 3: joined by. 7 00:00:20,720 --> 00:00:23,079 Speaker 4: Bloomberg's Bailey Lipshaltz Billybody looking up. 8 00:00:23,160 --> 00:00:25,119 Speaker 3: Yeah, some of the best performing stocks in the S 9 00:00:25,160 --> 00:00:28,440 Speaker 3: and P five hundred this morning are in the airline space. 10 00:00:28,520 --> 00:00:32,040 Speaker 3: This comes after Delta Air ticker dl reported earnings that 11 00:00:32,120 --> 00:00:36,000 Speaker 3: beat expectations and kind of talked up guidance for fourth 12 00:00:36,080 --> 00:00:38,240 Speaker 3: quarter and some of the strength they expect to continue 13 00:00:38,240 --> 00:00:41,160 Speaker 3: to see into twenty twenty six. So Delta Air shares 14 00:00:41,280 --> 00:00:44,239 Speaker 3: up about five and a half percent. Also keeping eye, 15 00:00:44,280 --> 00:00:46,800 Speaker 3: as I mentioned, United Health or United Airlines excuse me, 16 00:00:46,880 --> 00:00:47,800 Speaker 3: up close to four percent. 17 00:00:47,840 --> 00:00:49,080 Speaker 4: Alaska Air trading higher. 18 00:00:49,240 --> 00:00:52,159 Speaker 3: So this comes after management a bit more optimistic not 19 00:00:52,200 --> 00:00:55,720 Speaker 3: only on business demand but broader travel spending, saying that 20 00:00:55,760 --> 00:00:58,520 Speaker 3: they expect to see potentially a record fourth quarter for 21 00:00:58,600 --> 00:00:59,600 Speaker 3: the company. 22 00:00:59,360 --> 00:01:00,760 Speaker 4: People travel for holidays. 23 00:01:01,120 --> 00:01:03,400 Speaker 3: But also a thing to keep in mind, as Bloomberg 24 00:01:03,400 --> 00:01:05,400 Speaker 3: had reported earlier this morning, we're starting to see some 25 00:01:05,480 --> 00:01:07,960 Speaker 3: of those cracks showing up with the government shutdown, what 26 00:01:08,000 --> 00:01:11,240 Speaker 3: that means for the FAA and how that could impact it. 27 00:01:11,280 --> 00:01:14,000 Speaker 3: So management was asked about that, basically saying that, you know, 28 00:01:14,240 --> 00:01:17,640 Speaker 3: if this is extended, that could impact fourth quarter demand, 29 00:01:17,800 --> 00:01:19,480 Speaker 3: but for now they're not really seeing. 30 00:01:19,200 --> 00:01:22,080 Speaker 1: That show up absolutely all right, So Delta a clear 31 00:01:22,120 --> 00:01:24,880 Speaker 1: winner here. You're also keeping an eye on the pharmer space, 32 00:01:25,040 --> 00:01:26,760 Speaker 1: and there's some M and a yeah, m. 33 00:01:26,760 --> 00:01:30,759 Speaker 3: And a Novo Nordisk acquiring a Caro Therapeutics. So Novo 34 00:01:30,880 --> 00:01:34,319 Speaker 3: ADRs ticker ENVO down about one percent and a care 35 00:01:34,319 --> 00:01:37,440 Speaker 3: of Therapeutics up more than sixteen percent, trading about fifty 36 00:01:37,440 --> 00:01:40,000 Speaker 3: four dollars, So this is a four point seven billion 37 00:01:40,000 --> 00:01:44,119 Speaker 3: dollars deal that could be bumped up if the company's 38 00:01:44,480 --> 00:01:47,559 Speaker 3: drug is successful. So not only is there a fifty 39 00:01:47,560 --> 00:01:50,800 Speaker 3: four dollars cash component, there's also a contingent value right Basically, 40 00:01:50,960 --> 00:01:55,200 Speaker 3: Novo Nordisk trying to build out its weight loss opportunities. 41 00:01:55,560 --> 00:01:57,360 Speaker 3: A Caro is not in the weight loss space, but 42 00:01:57,400 --> 00:02:02,080 Speaker 3: treating the deadly liver disease is mash, not the TV show, 43 00:02:02,520 --> 00:02:05,200 Speaker 3: So this is something that could build out their portfolio. 44 00:02:05,280 --> 00:02:08,320 Speaker 3: Again looking through some of the quick analyst reactions, basically 45 00:02:08,320 --> 00:02:10,080 Speaker 3: saying Novo has a lot of wood to chop to 46 00:02:10,080 --> 00:02:11,880 Speaker 3: try to get back to where it was trading before. 47 00:02:12,120 --> 00:02:14,639 Speaker 3: Management talking up this acquisition saying that they want to 48 00:02:14,639 --> 00:02:16,600 Speaker 3: be able to treat not only the weight loss space, 49 00:02:16,639 --> 00:02:19,600 Speaker 3: but also other issues related to the liver fatty liver 50 00:02:19,680 --> 00:02:20,000 Speaker 3: as well. 51 00:02:20,280 --> 00:02:22,560 Speaker 1: Yeah, I'm looking at this and apparently MASH is one 52 00:02:22,600 --> 00:02:26,760 Speaker 1: of the most prevalent obesity related to comorbidities to so 53 00:02:27,200 --> 00:02:29,120 Speaker 1: you know, it's rounding outs portfolio in a very interesting 54 00:02:29,160 --> 00:02:29,800 Speaker 1: holistic way. 55 00:02:29,840 --> 00:02:31,160 Speaker 4: It all fits into that argument. 56 00:02:31,200 --> 00:02:34,000 Speaker 3: And really this does come after Novo's drug that they 57 00:02:34,000 --> 00:02:36,560 Speaker 3: were developing and the space failed, so this is kind 58 00:02:36,560 --> 00:02:39,040 Speaker 3: of trying to replace that. As we see again, not 59 00:02:39,080 --> 00:02:41,040 Speaker 3: only are some of the shot weight loss shots we 60 00:02:41,120 --> 00:02:44,680 Speaker 3: go vi ozepic being pretty successful, there is uncertainty again 61 00:02:44,919 --> 00:02:48,480 Speaker 3: with potential pills and also once those things lose their patents, 62 00:02:48,520 --> 00:02:50,080 Speaker 3: so trying to stay ahead of the game and trying 63 00:02:50,080 --> 00:02:52,959 Speaker 3: to build it out. This again, according to analyst expectations, 64 00:02:53,600 --> 00:02:57,000 Speaker 3: could be a billions upon billions of dollars of potential revenue, 65 00:02:57,040 --> 00:03:00,200 Speaker 3: so a big purchase for Novo Nordice. But again just 66 00:03:00,240 --> 00:03:02,119 Speaker 3: a small kind of step in the direction. 67 00:03:01,840 --> 00:03:04,639 Speaker 4: For the company. All Right, one more Walkware. Yeah, keep 68 00:03:04,639 --> 00:03:06,520 Speaker 4: an eye on MP materialsticker. 69 00:03:06,600 --> 00:03:09,720 Speaker 3: MP up about five percent, seeing a rally across US 70 00:03:09,760 --> 00:03:13,440 Speaker 3: listed rare earth and critical mineral stocks. This comes after 71 00:03:13,800 --> 00:03:17,000 Speaker 3: reports that China is going to apply a default ban 72 00:03:17,120 --> 00:03:20,680 Speaker 3: on defense sector exports of those materials, so investors piling 73 00:03:20,680 --> 00:03:22,880 Speaker 3: into companies that are tied to the US government trying 74 00:03:22,880 --> 00:03:25,000 Speaker 3: to secure some of those non China supply chains for 75 00:03:25,200 --> 00:03:25,640 Speaker 3: rare earths. 76 00:03:26,800 --> 00:03:30,840 Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with 77 00:03:30,919 --> 00:03:33,480 Speaker 2: us throughout the day for the latest roundup of companies 78 00:03:33,560 --> 00:03:36,680 Speaker 2: making news on Wall Street and for the latest market 79 00:03:36,680 --> 00:03:41,160 Speaker 2: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube, 80 00:03:41,240 --> 00:03:44,760 Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with 81 00:03:44,840 --> 00:03:46,320 Speaker 2: the Bloomberg Business app.